Browse EX-10 agreements

339441540 v11 Execution Version CREDIT AGREEMENT dated as of August 25, 2026, among CORE SCIENTIFIC, INC., as the Borrower, THE LENDERS AND ISSUING BANKS PARTY HERETO, JPMORGAN CHASE BANK, N.A., as Administrative Agent and Collateral Agent, MORGAN STANLEY SENIOR FUNDING, INC., JPMORGAN CHASE BANK, N.A., GOLDMAN SACHS LENDING PARTNERS LLC, AND TD SECURITIES (USA) LLC, as Joint Bookrunners

---

339441540 v11 -i- TABLE OF CONTENTS Page ARTICLE I DEFINITIONS ........................................................................................................................................ 1 Section 1.01 Defined Terms .................................................................................................................. 1 Section 1.02 Terms Generally; GAAP ................................................................................................ 42 Section 1.03 Letter of Credit Amounts ................................................................................................ 43 Section 1.04 Timing of Payment or Performa

…

SEPARATION AND RELEASE AGREEMENT

This Separation and Release Agreement (the “Agreement”) is made between Build-A-Bear Workshop, Inc., a Delaware corporation (the “Company”), and David Henderson (“Employee”) (each a “party” and together the “parties”):

WHEREAS, the Company entered into that certain Amended and Restated Employment, Confidentiality and Noncompete Agreement, which became effective as of June 11, 2026 (the “Employment Agreement”), with Employee, pursuant to which Employee currently serves as Chief Growth Officer of the Company.

WHEREAS, the Company now desires, pursuant to Section 4.1(c) thereof, to terminate the Employment Agreement and the Employee’s employment with the Company, without Cause (as defined therein), effective as of August 26, 2026 (the “Separation Date”).

WHEREAS, the parties wish to ensure an amicable separation and to provide for the release in full of all claims by Employee.

NOW, THEREFORE, the parties agree as follows:

…

** **

Form of Debt Forgiveness and Release Agreement

** **

Dated as of August 26, 2026

This Debt Forgiveness and Release Agreement (this “Agreement”), dated as of the date first set forth above (the “Effective Date”), is entered into by and between Jupiter Neurosciences, Inc., a Delaware corporation (the “Company”) and ____________ (“Counterparty”). Each of the Company and Counterparty may be referred to herein individually as a “Party” and collectively as the “Parties”.

RECITALS

WHEREAS, Counterparty is engaged by the Company as an employee, officer, consultant or in another position, and the Company currently owes the Counterparty the sum of $________ (the “Cash Debt”);

WHEREAS, Counterparty now desires to terminate and forgive The Cash Debt $_________ (the “Debt”), and provide the release and other agreements as set forth herein;

…

** **

AMENDMENT

TO THE

INVESTMENT MANAGEMENT TRUST AGREEMENT

This Amendment No. 7 (this “Amendment”), dated as of August 20, 2026, to the Investment Management Trust Agreement (as defined below) is made by and between Technology & Telecommunication Acquisition Corporation (the “Company”) and Continental Stock Transfer & Trust Company, as trustee (“Trustee”). All terms used but not defined herein shall have the meanings assigned to them in the Trust Agreement.

WHEREAS, the Company and the Trustee entered into an Investment Management Trust Agreement dated as of January 14, 2022 (as amended on by Amendment No. 1, Amendment No.2, Amendment No.3, Amendment No. 4 Amendment No. 5, and Amendment No. 6 thereto, the “Trust Agreement”);

WHEREAS, Section 1(i) of the Trust Agreement sets forth the terms that govern the liquidation of the Trust Account under the circumstances described therein;

…

AUTONOMIX MEDICAL, INC.

August 24, 2026

Holder of Common Stock Purchase Warrants

Re:         Inducement Offer to Exercise Common Stock Purchase Warrants

Dear Holder:

Autonomix Medical, Inc. (the “Company”) is pleased to offer to you the opportunity to exercise all of the Series D-1 warrants and Series D-2 warrants to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), issued to you on July 15, 2026 (the “Existing Warrants”), as set forth on the signature page hereto and currently held by you (the “Holder”). The issuance of the shares of Common Stock underlying the Existing Warrants (the “Warrant Shares”) has been registered for resale pursuant to the registration statement on Form S-3 (File No. 333-297760) (the “Registration Statement”). The Registration Statement is currently effective and, upon exercise of the Existing Warrants pursuant to this letter agreement, will be effective for the resale of the Warrant Shares.** **Capitalized terms not otherwise defined herein shall have the meanings set forth in the New Warran

…

BIOMERICA, INC.

SECURITIES PURCHASE AGREEMENT

This SECURITIES Purchase Agreement (this “Agreement”) is dated as of August 20, 2026, by and between Biomerica, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, “Purchaser” and collectively the “Purchasers”).

Whereas, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and/or Rule 506 of Regulation D promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

Now, Therefore, in consideration of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

Article I

DEFINITIONS

…

** **

BIOMERICA, INC.

** **

REGISTRATION RIGHTS AGREEMENT

** **

This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 20, 2026, by and between Biomerica, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

This Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the “Purchase Agreement”).

The Company and each Purchaser hereby agree as follows:

1. Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings:

“Advice” shall have the meaning set forth in Section 6(d).

…

EMPLOYMENT AGREEMENT

This Executive Employment Agreement (this “Agreement”) is entered into as of August 20, 2026, and is effective as of June 8, 2026 (the “Effective Date”), by and between Splash Beverage Group, Inc., a Nevada corporation (the “Company”), and Michael Bondurant (the “Executive”).

RECITALS

WHEREAS, the Company desires to employ the Executive as its Interim Chief Operating Officer (“COO”) and to ensure the continued availability of the Executive’s services on the terms and conditions set forth herein;

WHEREAS, the Executive desires to be employed by the Company on such terms and conditions;

WHEREAS, the Company is a publicly traded corporation whose common stock is listed on a national securities exchange and is subject to the reporting requirements of the Securities Exchange Act of 1934 (the “Exchange Act”);

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the Company and its stockholders to enter into this Agreement with the Executive; and

…

EMPLOYMENT AGREEMENT

This Executive Employment Agreement (this “Agreement”) is entered into as of August 20, 2026, and is effective as of June 8, 2026 (the “Effective Date”), by and between Splash Beverage Group, Inc., a Nevada corporation (the “Company”), and Brady Cobb (the “Executive”).

RECITALS

WHEREAS, the Company desires to employ the Executive as its Interim Chief Executive Officer (“CEO”) and to ensure the continued availability of the Executive’s services on the terms and conditions set forth herein;

WHEREAS, the Executive desires to be employed by the Company on such terms and conditions;

WHEREAS, the Company is a publicly traded corporation whose common stock is listed on a national securities exchange and is subject to the reporting requirements of the Securities Exchange Act of 1934 (the “Exchange Act”);

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the Company and its stockholders to enter into this Agreement with the Executive; and

…